These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11518084)

  • 21. Behavioral profile of Hypericum perforatum (St. John's Wort) extract. A comparison with standard antidepressants in animal models of depression.
    Bukhari IA; Dar A
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1082-9. PubMed ID: 23661522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
    Bouron A; Lorrain E
    Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of vesicular uptake of monoamines by hyperforin.
    Roz N; Mazur Y; Hirshfeld A; Rehavi M
    Life Sci; 2002 Sep; 71(19):2227-37. PubMed ID: 12215370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracts of St. John's wort and various constituents affect beta-adrenergic binding in rat frontal cortex.
    Simbrey K; Winterhoff H; Butterweck V
    Life Sci; 2004 Jan; 74(8):1027-38. PubMed ID: 14672758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort.
    Wonnemann M; Singer A; Siebert B; Müller WE
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S148-51. PubMed ID: 11518066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
    Muruganandam AV; Bhattacharya SK; Ghosal S
    Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models.
    Butterweck V; Christoffel V; Nahrstedt A; Petereit F; Spengler B; Winterhoff H
    Life Sci; 2003 Jun; 73(5):627-39. PubMed ID: 12770617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
    Barnes J; Anderson LA; Phillipson JD
    J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of St. John's wort (Hypericum perforatum) extract on 72-hour sleep deprivation-induced anxiety-like behavior and oxidative damage in mice.
    Kumar A; Singh A
    Planta Med; 2007 Oct; 73(13):1358-64. PubMed ID: 17918039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperforin--antidepressant activity by a novel mechanism of action.
    Müller WE; Singer A; Wonnemann M
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S98-102. PubMed ID: 11518085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways.
    Wonnemann M; Singer A; Müller WE
    Neuropsychopharmacology; 2000 Aug; 23(2):188-97. PubMed ID: 10882845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters.
    Gobbi M; Moia M; Pirona L; Morizzoni P; Mennini T
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mechanism of action of St. Johns wort extract].
    Müller WE; Singer A; Wonnemann M
    Praxis (Bern 1994); 2000 Dec; 89(50):2111-21. PubMed ID: 11155494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do other Hypericum species have medical potential as St. John's wort (Hypericum perforatum)?
    Stojanović G; Ðorđević A; Šmelcerović A
    Curr Med Chem; 2013; 20(18):2273-95. PubMed ID: 23521674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W; Schober F; Mannel M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro.
    Capasso R; Borrelli F; Capasso F; Mascolo N; Izzo AA
    Urology; 2004 Jul; 64(1):168-72. PubMed ID: 15245964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity.
    Jensen AG; Hansen SH; Nielsen EO
    Life Sci; 2001 Feb; 68(14):1593-605. PubMed ID: 11263672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypericum perforatum (St John's wort) beyond depression: A therapeutic perspective for pain conditions.
    Galeotti N
    J Ethnopharmacol; 2017 Mar; 200():136-146. PubMed ID: 28216196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L.).
    Nathan P
    Mol Psychiatry; 1999 Jul; 4(4):333-8. PubMed ID: 10483049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats.
    Butterweck V; Winterhoff H; Herkenham M
    Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.